Key Therap Drug Patent Portfolio
Key Therap owns 1 orange book drug protected by 3 US patents Given below is the list of Key Therap's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7304078 | Thrombin receptor antagonists | 23 Dec, 2027 | Active |
| US7713999 | Thrombin receptor antagonists | 30 May, 2024 | Expired |
| US7235567 | Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist | 13 Jun, 2021 | Expired |
Latest Legal Activities on Key Therap's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Key Therap.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Court Processing Terminated | 02 Apr, 2024 | US7304078 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 29 Sep, 2021 | US7713999 |
|
Email Notification
Critical
| 09 Nov, 2020 | US7713999 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 09 Nov, 2020 | US7713999 |
|
Correspondence Address Change
Critical
| 05 Nov, 2020 | US7713999 |
|
Email Notification
Critical
| 03 Nov, 2020 | US7235567 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 03 Nov, 2020 | US7235567 |
|
Correspondence Address Change
Critical
| 01 Nov, 2020 | US7235567 |
|
Patent Term Extension Certificate
Critical
| 03 Sep, 2020 | US7304078 |
| Notice of Final Determination -Eligible | 29 Jun, 2020 | US7304078 |
|
FDA Final Eligibility Letter
Critical
| 07 Mar, 2019 | US7304078 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 13 Dec, 2018 | US7235567 |
|
Accelerated Examination Request
Critical
| 31 Aug, 2018 | US7304078 |
| transaction for FDA Determination of Regulatory Review Period | 15 Feb, 2018 | US7304078 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 26 Oct, 2017 | US7713999 |
Key Therap's Family Patents
Key Therap Drug List
Given below is the complete list of Key Therap's drugs and the patents protecting them.
1. Zontivity
Zontivity is protected by 3 patents, out of which 2 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7304078 | Thrombin receptor antagonists |
23 Dec, 2027
(2 years from now)
| Active |
| US7713999 | Thrombin receptor antagonists |
30 May, 2024
(1 year, 4 months ago)
| Expired |
| US7235567 | Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
13 Jun, 2021
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zontivity's drug page